Successful off-label therapy of advanced cutaneous angiosarcomas with ipilimumab and nivolumab after failure of conventional treatment approaches.

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

https://programme.conventus.de/ado-2026/program/program-points/26a435ef-d118-4c9c-b9ad-96dbb79aff69

Dr. Magdalena-Sophie Greiner; Dr. Magdalena-Sophie Greiner; Dr. Jan Hendrik Maiwald; Dr. Simon Goller; Prof. Dr. Matthias Goebeler; Dr. Valerie Glutsch; Prof. Ugur Uslu; Dr. Anja Gesierich

Sep 7, 2026